Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Ortho clinical diagnostics (ortho) has initiated this recall due to a potential for negatively biased serum sample results to be generated when using vitros ca slides gen 29. ortho confirmed an average negative bias of -0.45 mg/dl (-0.11 mmol/l) within the serum reference interval (8.4 - 10.2 mg/dl or (2.10 - 2.55 mmol/l) when using vitros ca slides gen 29. plasma and serum samples are similarly affected as both sample types use the same calibration parameters (math) when results are produced. though unconfirmed to date ortho has no indication that urine sample results generated when using vitros ca slides gen 29 are affected. as a result customers are being instructed to discontinue the use of vitros ca slides gen 29.